Form 4 holding
Director
Denali Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 336,313
- Estimated value
- $6,457,209
- Report date
- 03 Jun 2026
- Price
- $19.20
- Ownership
- Indirect
Flatley Jay T. - Director at Denali Therapeutics Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- DNLI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Flatley Jay T. since 03 Aug 2025
Reported holdings for Flatley Jay T. in Denali Therapeutics Inc.
Form 4 holding
Director
Denali Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 22,628
- Estimated value
- $434,457
- Report date
- 03 Jun 2026
- Price
- $19.20
- Ownership
- Direct
Form 4 holding
Director
Denali Therapeutics Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 19,226
- Estimated value
- Report date
- 03 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Flatley Jay T. in Denali Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.